Anthony Maraveyas

14.0k total citations · 3 hit papers
165 papers, 8.4k citations indexed

About

Anthony Maraveyas is a scholar working on Oncology, Internal Medicine and Surgery. According to data from OpenAlex, Anthony Maraveyas has authored 165 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Oncology, 61 papers in Internal Medicine and 36 papers in Surgery. Recurrent topics in Anthony Maraveyas's work include Venous Thromboembolism Diagnosis and Management (61 papers), Blood Coagulation and Thrombosis Mechanisms (25 papers) and Pancreatic and Hepatic Oncology Research (23 papers). Anthony Maraveyas is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (61 papers), Blood Coagulation and Thrombosis Mechanisms (25 papers) and Pancreatic and Hepatic Oncology Research (23 papers). Anthony Maraveyas collaborates with scholars based in United Kingdom, United States and Italy. Anthony Maraveyas's co-authors include Juan W. Valle, John Bridgewater, Harpreet Wasan, Alan Anthoney, Daniel H. Palmer, David Cunningham, Srinivasan Madhusudan, Timothy Iveson, Sy Ha and S. Hughes and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Anthony Maraveyas

156 papers receiving 8.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

2010 3.0k citations Juan W. Valle, Harpreet Wasan et al. profile →
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

2018 855 citations Annie Young, Andrea Marshall et al. Journal of Clinical Oncology profile →
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline

2023 172 citations Anna Falanga, Cihan Ay et al. Annals of Oncology profile →

Peers

Countries citing papers authored by Anthony Maraveyas

Since Specialization

Citations

This map shows the geographic impact of Anthony Maraveyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Maraveyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Maraveyas more than expected).

Fields of papers citing papers by Anthony Maraveyas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Maraveyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Maraveyas. The network helps show where Anthony Maraveyas may publish in the future.

Co-authorship network of co-authors of Anthony Maraveyas

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Maraveyas. A scholar is included among the top collaborators of Anthony Maraveyas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Maraveyas. Anthony Maraveyas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quantitative proteomics reveals CLR interactome in primary human cells 2024 ·Journal of Biological Chemistry ·(unknown), (unknown), Anthony Maraveyas, Darragh P. O’Brien, Benedikt M. Kessler, (unknown), Leonid L. Nikitenko	0
2	Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline breakdown → 2023 ·Annals of Oncology ·Anna Falanga, Cihan Ay, Marcello Di Nisio, Grigoris Gerotziafas, Luis Jara‐Palomares, (unknown), Ramón Lecumberri, Mario Mandalà, Anthony Maraveyas, (unknown), M. Sinn, K. Syrigos, Annie Young, Karin Jordan	172
3	Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PRECISE): a case series 2023 ·BMC Sports Science Medicine and Rehabilitation ·Malcolm Brown, Dominic O’Connor, Richard Turkington, Martin Eatock, Rebecca V. Vince, Claire Hulme, (unknown), R.L. Robinson, Jonathan Wadsley, Anthony Maraveyas, Gillian Prue	1
4	Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology: Guidance from the SSC of the ISTH 2022 ·Journal of Thrombosis and Haemostasis ·Tzu‐Fei Wang, Kristen M. Sanfilippo, James D. Douketis, Anna Falanga, (unknown), Anthony Maraveyas, Thomas L. Ortel, Gerald A. Soff, Suresh Vedantham, Jeffrey I. Zwicker	7
5	Practical treatment guidance for cancer-associated thrombosis – Managing the challenging patient: A consensus statement 2022 ·Critical Reviews in Oncology/Hematology ·Kathryn Musgrave, (unknown), Michael Laffan, James S. O’Donnell, Jecko Thachil, Anthony Maraveyas	7
6	Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials 2022 ·Journal of Clinical Medicine ·Konstantinos G. Kyriakoulis, Evangelos Dimakakos, (unknown), M. Catalano, Alex C. Spyropoulos, Sam Schulman, James D. Douketis, Anna Falanga, Anthony Maraveyas, Dan-Mircea Olinic, J. J. F. Belch, Grigoris Gerotziafas, Konstantinos Syrigos, Αναστάσιος Κόλλιας	10
7	Standardization of risk prediction model reporting in cancer‐associated thrombosis: Communication from the ISTH SSC subcommittee on hemostasis and malignancy 2022 ·Journal of Thrombosis and Haemostasis ·Kristen M. Sanfilippo, Tzu‐Fei Wang, Marc Carrier, Anna Falanga, Brian F. Gage, Alok A. Khorana, Anthony Maraveyas, Gerald A. Soff, Philip S. Wells, Jeffrey I. Zwicker	4
8	Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art 2022 ·Anticancer Research ·Evangelos Dimakakos, Georgia Gomatou, M. Catalano, Dan-Mircea Olinic, Alex C. Spyropoulos, Anna Falanga, Anthony Maraveyas, Aaron Liew, Sam Schulman, J. J. F. Belch, Grigoris Gerotziafas, Peter Marschang, Benilde Cosmi, Jonas Spaak, Konstantinos Syrigos	6
9	The prognostic value of respiratory symptoms and performance status in ambulatory cancer patients and unsuspected pulmonary embolism; analysis of an international, prospective, observational cohort study 2021 ·Journal of Thrombosis and Haemostasis ·Anthony Maraveyas, Noémie Kraaijpoel, George Bozas, Chao Huang, Isabelle Mahé, Laurent Bertoletti, Annemarieke Bartels‐Rutten, Jan Beyer‐Westendorf, J. Constans, (unknown), Françis Couturaud, Andrés J. Muñoz Martín, M. Biosca, Teresa Lerede, Nick van Es, Marcello Di Nisio	7
10	Accumulation of tissue factor in endothelial cells promotes cellular apoptosis through over-activation of Src1 and involves β1-integrin signalling 2019 ·APOPTOSIS ·(unknown), (unknown), (unknown), (unknown), Anthony Maraveyas, John Greenman, Camille Ettelaie	13
11	Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D) breakdown → 2018 ·Journal of Clinical Oncology ·Annie Young, Andrea Marshall, (unknown), Oliver Chapman, Anand Lokare, Catherine St. Hill, Danielle Hale, Janet Dunn, Gary H. Lyman, Charles Hutchinson, Peter MacCallum, Ajay K. Kakkar, Richard Hobbs, Stavros Petrou, Jeremy Dale, Christopher Poole, Anthony Maraveyas, Mark N. Levine	855
12	COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study 2018 ·Thrombosis Journal ·(unknown), Alexander T. Cohen, Anthony Maraveyas, Jan Beyer‐Westendorf, Agnes Lee, LG Mantovani, (unknown)	20
13	Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial 2018 ·British Journal of Cancer ·Alison Backen, Andre Lopes, Harpreet Wasan, Daniel H. Palmer, Marian Duggan, David Cunningham, Alan Anthoney, Pippa Corrie, Srinivasan Madhusudan, Anthony Maraveyas, Paul J. Ross, Justin S. Waters, William P. Steward, Charlotte Rees, Mairéad G. McNamara, Sandy Beare, John Bridgewater, Caroline Dive, Juan W. Valle	22
14	Tissue factor‐bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer 2017 ·Journal of Thrombosis and Haemostasis ·Kathryn Date, Camille Ettelaie, Anthony Maraveyas	61
15	Assessing patients' anticoagulation preferences for the treatment of cancer-associated thrombosis using conjoint methodology 2015 ·Haematologica ·Simon Noble, Axel Matzdorff, Anthony Maraveyas, (unknown), (unknown)	85
16	p38α phosphorylates serine 258 within the cytoplasmic domain of tissue factor and prevents its incorporation into cell-derived microparticles 2012 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Camille Ettelaie, (unknown), Anthony Maraveyas, (unknown)	22
17	Pancreatic cancer cell and microparticle procoagulant surface characterization 2011 ·Blood Coagulation & Fibrinolysis ·(unknown), (unknown), (unknown), John Greenman, Anthony Maraveyas, Leigh A. Madden	34
18	A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma 2009 ·Clinical Cancer Research ·Jeffrey S. Weber, John A. Thompson, Omid Hamid, David R. Minor, Asim Amin, Ilan G. Ron, Ruggero Ridolfi, Hazem Assi, Anthony Maraveyas, David M. Berman, Jonathan Siegel, Steven O’Day	460
19	Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy (vol 94, pg 1554, 2006) 2006 ·UCL Discovery (University College London) ·(unknown), A. Chaturvedi, Anne M. Hubbard, (unknown), M. Lowry, Anthony Maraveyas, (unknown), (unknown), LW Turnbull	1
20	Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody 1993 ·British Journal of Cancer ·V Hird, Anthony Maraveyas, D Snook, B Dhokia, W. P. Soutter, Claude F. Meares, (unknown), P. R. Mason, (unknown), (unknown)	132

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact